Cosmos Health Inc. COSM
Set alert
0.31 USD +0.03 +10.95%
At close · Oct 30
0.31 0.00 +0.58%
After hours · Oct 30, 7:55 PM ET
0.27 Day range 0.31
0.172 52-week range 0.90
- YTD
- -38.17%
- 1 year
- -65.79%
- Open
- 0.2713
- Prev close
- 0.2775
- Mkt cap
- 30.99M
- Vol
- 2.11M
- Avg vol
- 3.17M
- EPS
- -0.65
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.27
- High
- 0.31
- Forward P/E
- -12.36
- Beta
- 3.14
- Short ratio
- 2.56
- Inst. own
- 10.28%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 20, 2024
- 50-d avg
- 0.73594
- 200-d avg
- 0.84244
- 1y target
- 3.00
MAX chart
Events in this range
- Aug 6, 2024Earnings: —; estimate 0; surprise —%
Signals (68)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 1 day ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jun 1, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 1, 2023 | 3 years ago |
| SMA: Bearish | Jul 1, 2023 | 3 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 1, 2022 | 3 years ago |
| RSI: Oversold | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | Nov 1, 2021 | 5 years ago |
| MACD: Sell Signal | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Jul 1, 2021 | 5 years ago |
| SMA: Bullish | Oct 1, 2020 | 6 years ago |
| SMA: Bearish | Sep 1, 2020 | 6 years ago |
| SMA: Bullish | Aug 1, 2020 | 6 years ago |
| SMA: Bullish | Jun 1, 2020 | 6 years ago |
| MACD: Buy Signal | May 1, 2020 | 6 years ago |
| SMA: Bearish | Oct 1, 2019 | 7 years ago |
| SMA: Bullish | Sep 1, 2019 | 7 years ago |
| SMA: Bearish | Dec 1, 2018 | 7 years ago |
| SMA: Bearish | Dec 1, 2018 | 7 years ago |
| SMA: Bullish | Nov 1, 2018 | 8 years ago |
| SMA: Bullish | Nov 1, 2018 | 8 years ago |
| SMA: Bearish | Jun 1, 2018 | 8 years ago |
| MACD: Sell Signal | Jun 1, 2018 | 8 years ago |
| SMA: Bullish | May 1, 2018 | 8 years ago |
| SMA: Bearish | Apr 1, 2018 | 8 years ago |
| SMA: Bearish | Apr 1, 2018 | 8 years ago |
| SMA: Bullish | Nov 1, 2017 | 9 years ago |
| SMA: Bullish | Nov 1, 2017 | 9 years ago |
| MACD: Buy Signal | Nov 1, 2017 | 9 years ago |
| MACD: Sell Signal | Jul 1, 2017 | 9 years ago |
| SMA: Bearish | Apr 1, 2017 | 9 years ago |
| SMA: Bullish | Dec 1, 2016 | 9 years ago |
| SMA: Bullish | Dec 1, 2016 | 9 years ago |
| MACD: Buy Signal | Dec 1, 2016 | 9 years ago |
| SMA: Bearish | Nov 1, 2016 | 10 years ago |
| SMA: Bullish | Oct 1, 2016 | 10 years ago |
| SMA: Bearish | Sep 1, 2016 | 10 years ago |
| SMA: Bullish | Jul 1, 2016 | 10 years ago |
| SMA: Bearish | Apr 1, 2016 | 10 years ago |
| SMA: Bullish | Mar 1, 2016 | 10 years ago |
| SMA: Bearish | Jan 1, 2016 | 10 years ago |
| SMA: Bullish | Oct 1, 2015 | 11 years ago |
| SMA: Bearish | Aug 1, 2015 | 11 years ago |
| SMA: Bearish | Aug 1, 2015 | 11 years ago |
| SMA: Bullish | Jul 1, 2015 | 11 years ago |
| SMA: Bullish | Jul 1, 2015 | 11 years ago |
| SMA: Bearish | Feb 1, 2015 | 11 years ago |
| MACD: Sell Signal | Oct 1, 2014 | 12 years ago |
| SMA: Bearish | Jul 1, 2014 | 12 years ago |
| SMA: Bullish | Aug 1, 2013 | 13 years ago |
| SMA: Bearish | May 1, 2013 | 13 years ago |
| SMA: Bullish | Apr 1, 2013 | 13 years ago |
| SMA: Bullish | Mar 1, 2013 | 13 years ago |
| SMA: Bearish | Dec 1, 2012 | 13 years ago |
| SMA: Bullish | Nov 1, 2012 | 14 years ago |
| SMA: Bearish | Oct 1, 2012 | 14 years ago |
| SMA: Bullish | Sep 1, 2012 | 14 years ago |
| SMA: Bearish | Sep 1, 2011 | 15 years ago |
| SMA: Bullish | Aug 1, 2011 | 15 years ago |
| SMA: Bearish | Jun 1, 2011 | 15 years ago |
Key statistics
- Market cap
- 14.37M
- Enterprise value
- 22.63M
- Trailing P/E
- 0.00
- Forward P/E
- -12.36
- PEG ratio
- 0.00
- Price / sales
- 0.25
- Price / book
- 0.27
- EPS (TTM)
- -2.45
- Beta
- 3.14
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -38.19%
- Revenue (TTM)
- 56.45M
- Revenue growth
- 6.80%
- Free cash flow
- -6.86M
- Total cash
- 365.02K
- Total debt
- 11.81M
- Return on equity
- -56.61%
- Shares outstanding
- 23.26M
- Short % of float
- 1.97%
- 50-day average
- 0.73594
- 200-day average
- 0.84244
Analyst view
Consensus: none
Price target (mean) 3.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 20, 2024
Expected Aug 20, 2024. Consensus EPS estimate -0.09.
Financials — quick view
COSM Revenue — quarterly 18.99M
COSM Net income — quarterly -6.09M
COSM EPS — quarterly -0.10
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.11 | -0.45 | -0.34 | -309.09% |
| Aug 20, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Aug 20, 2024 | Jun 1, 2024 | -0.14 | -0.09 | +0.05 | +35.71% |
| Aug 20, 2024 | Jun 1, 2024 | -0.14 | — | — | — |
| Aug 20, 2024 | Mar 1, 2024 | 0.00 | -0.04 | — | — |
| Aug 6, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- cosmosholdingsinc.com
News
- Cosmos Health Announces Expansion Of Its E-Commerce, Subscription Operations To Australia, New Zealand, Oceania Region
- Cosmos Health Expects Q4 Sales Of ~$15M, Gross Profit Of ~$10.5M With Gross Margin Of ~70%
- Cosmos Health Reaches 6,287 Active U.S. Subscriptions Generating ~$920K In Monthly Renewal Value; 60.5% Of Online Orders Include Subscriptions, Rising To More Than 75% In Recent Days As Adoption Accelerates
- Cosmos Health Record One-Day U.S. Direct-To-Consumer Sales Of $92K+ On October 11 And $902K In 30 Days
- Cosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M
- Cosmos Health's Cana Laboratories Subsidiary Achieves Over $20M In Revenue
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Cosmos Health Signs Exclusive Distribution Agreement With Saudi Pharmacy Innova Healthcare For 126K Units Of Its Proprietary Sky Premium Life Range Of Food Supplements
- Cosmos Health Q2 EPS $(0.10) Misses $0.01 Estimate, Sales $18.986M Miss $19.420M Estimate
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Your note
Sign in to keep a note on COSM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ASLIDIS ANASTASIOS | Director | Stock Award(Grant) | Apr 2, 2023 | 20,200 |
| BARDAKIS NIKOLAOS | Chief Operating Officer | Stock Award(Grant) | Apr 2, 2023 | 10,000 |
| HOIDAS JOHN JAMES | Director | Stock Award(Grant) | Apr 2, 2023 | 5,000 |
| IGNATIADES PAVLOS | Officer | Stock Award(Grant) | Apr 2, 2023 | 5,000 |
| SIOKAS GRIGORIOS | Chief Executive Officer | Purchase | Feb 15, 2024 | 1,394,600 |
| TERZIS GEORGIOS | Chief Financial Officer | Stock Award(Grant) | Oct 23, 2023 | 152,459 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 7.13% | 1,658,850 | 1.03M | Sep 29, 2024 |
| Blackrock Inc. | 1.15% | 267,797 | 165.50K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.64% | 149,728 | 92.53K | Sep 29, 2024 |
| Vanguard Group Inc | 0.58% | 134,834 | 83.33K | Sep 29, 2024 |
| UBS Group AG | 0.50% | 115,667 | 71.48K | Sep 29, 2024 |
| State Street Corporation | 0.11% | 24,743 | 15.29K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.58% | 134,834 | 83.33K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.39% | 89,961 | 55.59K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 22,653 | 14.00K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.09% | 21,794 | 13.47K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 4,515 | 2.79K | Oct 30, 2024 |